Search
Search Results
##search.searchResults.foundPlural##
-
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4487PDF: 1660HTML: 4100Tables and Images: 247 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3287PDF: 1040HTML: 2144 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2687PDF: 763HTML: 2320 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4504PDF: 1749HTML: 1109 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3765PDF: 1127HTML: 2448Figure 1: 216 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1063PDF: 561HTML: 7821 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3640PDF: 2556HTML: 1525 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4624PDF: 1541HTML: 1565Untitled: 243 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1439PDF: 838HTML: 3126 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4122PDF: 1170HTML: 2005Fig.1: 223Fig. 2: 116Table 1: 210Table2: 230Table 3: 206 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1612PDF: 1065HTML: 263 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3279PDF: 796HTML: 2978Figure 1a and 1b: 160Figure 2: 167Figure 3: 187Figure 4: 169Figure 5: 171Tables 1-5: 158 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3308PDF: 1482HTML: 5959Fig1-Ag-Pil: 244Ag-Pil Fig.2: 245 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7744PDF: 2456HTML: 1745Table 1.: 228Table 2.: 240Table 3.: 222Table 4.: 216 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1236PDF: 612HTML: 6806 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2386PDF: 1677HTML: 305 -
Pathologic splenic rupture in a patient with follicular lymphoma
1459PDF: 566HTML: 1197rupture: 188 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3446PDF: 1314HTML: 2234Fi.1 Gritti.Rambaldi: 218 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2414PDF: 1877HTML: 155 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3362PDF: 1268HTML: 2216 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3115PDF: 890HTML: 7180Kost Fig1: 201Kost Fig 2: 191Kost Fig3: 193Kost Fig 4: 204Kost Fig5: 203Kost fig 6: 189 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1396HTML: 334PDF: 971Suppl. Files: 477 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3763PDF: 1645HTML: 84 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2591PDF: 864HTML: 8919Efremov 1: 244Efremov 2: 208 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1210PDF: 563HTML: 216 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1798PDF: 892HTML: 389Fig1: 248Fig.2: 261Fig. 3: 199Fig. 5: 211Fig. 4: 234 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2579PDF: 960HTML: 356 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2954PDF: 1390HTML: 3583Untitled: 203Untitled: 216Untitled: 191







